Algert Global’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.13M	Sell	140,462 -473,948	-77%	-$11.3M	0.05%	585
2025 Q4	$16.4M	Buy	614,410 +214,301	+54%	+$5.12M	0.26%	90
2025 Q3	$8.54M	Buy	400,109 +347,017	+654%	+$8.21M	0.14%	231
2025 Q2	$1.15M	Sell	53,092 -296,612	-85%	-$5.51M	0.02%	780
2025 Q1	$5.81M	Sell	349,704 -136,200	-28%	-$2.47M	0.14%	223
2024 Q4	$8.92M	Sell	485,904 -63,552	-12%	-$1.03M	0.21%	139
2024 Q3	$8.45M	Buy	549,456 +15,313	+3%	+$255K	0.23%	112
2024 Q2	$8.68M	Buy	534,143 +179,799	+51%	+$2.9M	0.29%	64
2024 Q1	$6.55M	Buy	354,344 +93,467	+36%	+$2.32M	0.26%	96
2023 Q4	$8.17M	Buy	260,877 +149,343	+134%	+$3.57M	0.33%	50
2023 Q3	$2.32M	Buy	111,534 +380	+0.3%	+$10.3K	0.11%	313
2023 Q2	$2.66M	Sell	111,154 -30,510	-22%	-$678K	0.12%	286
2023 Q1	$2.67M	Sell	141,664 -32,855	-19%	-$626K	0.13%	248
2022 Q4	$2.78M	Sell	174,519 -3,193	-2%	-$49.9K	0.15%	195
2022 Q3	$2.91M	Buy	177,712 +11,581	+7%	+$188K	0.18%	162
2022 Q2	$2.34M	Buy	166,131 +62,079	+60%	+$1.16M	0.18%	141
2022 Q1	$2.52M	Buy	104,052 +67,620	+186%	+$1.64M	0.17%	157
2021 Q4	$850K	Buy	36,432 +16,370	+82%	+$329K	0.11%	326
2021 Q3	$333K	Buy	+20,062	New	+$387K	0.04%	718
2021 Q1	–	Sell	-6,897	Closed	-$369K	–	428
2020 Q4	$369K	Hold	6,897	–	–	0.11%	268
2020 Q3	$285K	Sell	6,897 -5,040	-42%	-$218K	0.09%	265
2020 Q2	$579K	Sell	11,937 -11,672	-49%	-$560K	0.2%	166
2020 Q1	$997K	Buy	+23,609	New	+$973K	0.42%	71
2019 Q4	–	Sell	-7,370	Closed	-$265K	–	374
2019 Q3	$265K	Buy	+7,370	New	+$223K	0.1%	236